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Background: Periodontitis is a polymicrobial biofilm-induced inflammatory disease that affects 743 million people
worldwide. The current model to explain periodontitis progression proposes that changes in the relative abundance
of members of the oral microbiome lead to dysbiosis in the host-microbiome crosstalk and then to inflammation
and bone loss. Using combined metagenome/metatranscriptome analysis of the subgingival microbiome in progressing
and non-progressing sites, we have characterized the distinct molecular signatures of periodontitis progression.
Methods: Metatranscriptome analysis was conducted on samples from subgingival biofilms from progressing and stable
sites from periodontitis patients. Community-wide expression profiles were obtained using Next Generation Sequencing
(Illumina). Sequences were aligned using ‘bowtie2’ against a constructed oral microbiome database. Differential expression
analysis was performed using the non-parametric algorithm implemented on the R package ‘NOISeqBio’. We summarized
global functional activities of the oral microbial community by set enrichment analysis based on the Gene
Ontology (GO) orthology.
Results: Gene ontology enrichment analysis showed an over-representation in the baseline of active sites of
terms related to cell motility, lipid A and peptidoglycan biosynthesis, and transport of iron, potassium, and
amino acids. Periodontal pathogens (Tannerella forsythia and Porphyromonas gingivalis) upregulated different
TonB-dependent receptors, peptidases, proteases, aerotolerance genes, iron transport genes, hemolysins,
and CRISPR-associated genes. Surprisingly, organisms that have not been usually associated with the disease
(Streptococcus oralis, Streptococcus mutans, Streptococcus intermedius, Streptococcus mitis, Veillonella parvula, and
Pseudomonas fluorenscens) were highly active transcribing putative virulence factors. We detected patterns of
activities associated with progression of clinical traits. Among those we found that the profiles of expression
of cobalamin biosynthesis, proteolysis, and potassium transport were associated with the evolution towards
disease.
Conclusions: We identified metabolic changes in the microbial community associated with the initial stages of
dysbiosis. Regardless of the overall composition of the community, certain metabolic signatures are consistent
with disease progression. Our results suggest that the whole community, and not just a handful of oral pathogens,
is responsible for an increase in virulence that leads to progression.
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Much has been learned about the diversity and distribu-
tion of oral associated microbial communities, but we
still know little about the biology of the microbiome,
how it interacts with the host, and how the host re-
sponds to its resident microbiota. The oral cavity offers
a unique opportunity to study how microbial communi-
ties have an influence on the health status of their
human host. Imbalances of the oral microbiota, also re-
ferred to as microbial dysbiosis, lead to a series of differ-
ent oral diseases. These dysbiotic microbial communities
exhibit synergistic interactions for enhanced protection
from host defenses, nutrient acquisition, and persistence
in an inflammatory environment [1,2]. Periodontitis is
an oral polymicrobial disease caused by the coordinated
action of a complex microbial community, which results
in inflammation and destruction of the periodontium in
susceptible hosts. Periodontal disease is the sixth most
prevalent health condition in the world affecting 743
million people worldwide [3]. It occurs in moderate
form in 30% to 50% of American adults and in severe
form in 10% of the population and is responsible for half
of all tooth loss in adults [4,5]. In addition, recent studies
have suggested that periodontal diseases can influence the
risk for certain systemic conditions such as cardiovascular
diseases, diabetes, respiratory diseases, and can affect repro-
ductive outcomes [6,7].
Using checkerboard, a DNA-DNA hybridization tech-
nique, periodontitis-associated taxa have been cataloged
into groups or complexes, representing bacterial consor-
tia that appear to occur together and that are associated
with various stages of disease [7]. The red complex,
which appears later in biofilm development, comprises
three species that are considered to be the major peri-
odontal pathogens: Porphyromonas gingivalis, Trepo-
nema denticola, and Tannerella forsythia [7,8]. Another
important group of organisms that has been associated
with chronic periodontitis is the orange complex consti-
tuted by: Fusobacterium nucleatum, Prevotella intermedia,
Prevotella nigrescens, Parvimonas micra, Streptococcus con-
stellatus, Eubacterium nodatum, Campylobacter showae,
Campylobacter gracilis, and Campylobacter rectus. Similar
to the red complex, all species in the orange complex have
been shown to have a significant association with increasing
pocket depth [7,9] and reciprocal interactions between both
have been proposed [9]. In more recent studies using 454
pyrosequencing to characterize healthy and periodontitis
microbial communities [10,11], the overall picture of
bacterial associations with health and disease agree
with the initial descriptions of the different oral mi-
crobial complexes.
One key question to be answered regarding the patho-
genesis of polymicrobial diseases is what the molecular
mechanisms that lead to dysbiosis are. In the case ofperiodontitis, why in some cases teeth with clinical
symptoms of periodontitis progress leading to tooth loss
(if untreated) and in some other cases the progression of
the disease stops despite lack of treatment [12]. There
have been a large number of attempts to identify reliable
markers that would distinguish between progressing and
non-progressing sites. These include genetic markers
[13,14], protein activity [15,16], cytokines [17,18], and bac-
terial [19,20] and clinical markers [19]. However, none of
these associations explain why progression occurs.
Current models of periodontal disease progression
posit that tissue destruction occurs through periods of
acute exacerbations (activity) followed by periods of re-
mission [21,22]. It has been postulated that changes in
the composition of subgingival biofilms could explain
these periods of disease activity. In fact, a few papers
have found differences in the levels of subgingival spe-
cies when comparing progressing and non-progressing
sites using cultivation techniques [23] and molecular ap-
proaches such as real-time PCR [20]. However, these
studies also demonstrated considerable overlap in the
composition of the microbial communities associated
with active and non-progressing lesions, suggesting that
the difference in the periodontal status of the sites could
not be explained solely by the reported differences in the
subgingival microbial composition.
Cataloging the activities of each bacterial species in a
community may provide more insight into pathogenesis
than simple enumeration of that community’s gene con-
tent. This is because the community functions as a sys-
tem, and its activities and interactions control the fate of
the microbiome.
The goal of the present study was to characterize in
situ gene expression patterns of the whole oral micro-
biome during periodontitis progression to identify early
steps in dysbiosis that could answer the question of why
only certain teeth progress to disease while others do
not.
Methods
Ethics statement
Written informed consent was obtained from all partici-
pants in this study. Recruitment of study participants
was performed according to protocol (ClinicalTrials.gov
ID NCT01489839) approved by Forsyth Institutional
Review Board ID #11-09 (Approval Date 8 August 2014)
in Cambridge, MA, USA. All subjects provided written
signed informed consent prior to participation.
Power calculation
In order to assess the sample size required we used the
R package RNASeqPower [24]. We first estimated the
average coverage using samtools depth command from
the samtools package [25]. According to this analysis,
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eight subjects in each group to have a power of 0.9.
Study design, subject population, and sample collection
The subjects in the present study were recruited as part
of a multi-center clinical trial to determine biomarkers
of periodontal disease progression (Clinical Trials.gov ID
NCT01489839). Under this ongoing study, subjects are
monitored clinically for a period of up to 1 year every 2
months in order to detect periodontal sites and subjects
with periodontal disease progression. Subgingival micro-
bial samples are collected from up to 32 sites per subject
per visit. The Institutional Review Board at The Forsyth
Institute approved all aspects of the study protocol. The
study was described thoroughly to all subjects prior to
obtaining informed consent. Inclusion criteria were: age
>24 years; ≥20 natural teeth (excluding third molars); at
least four teeth with at least one site of pocket depth
(PD) of 5 mm or more and concomitant clinical attach-
ment loss (CAL) greater than or equal to 2 mm; radio-
graphic evidence of mesial or distal alveolar bone loss
around at least two of the affected teeth; and in good
general health (Table 1). Exclusion criteria were: current
cigarette smokers; pregnant or nursing; received anti-
biotic or periodontal therapy in the previous 6 months;
any systemic condition potentially affecting the course
of periodontal disease (for example, diabetes or AIDS);
chronic use of non-steroidal anti-inflammatory drugs; or
any condition requiring antibiotic coverage for dental
procedures. Disease progression at a site was defined by
an increase in CAL ≥2 mm at any follow-up visit com-
pared with baseline. Stable sites were characterized by
no change in CAL >1 mm from baseline. Eight stable
sites and eight progressing sites from the nine subjects
were analyzed (Table 2). We collected one stable site
and one progressing site, both at baseline and at the
endpoint of analysis. For seven of the nine subjects, both
progressing and stable sites matched the initial baselines.
Samples were processed as described below.Table 1 Clinical and demographic characteristics of study sub
Subject Age (years) Mean PD (mm)
1 53 2.1
2 32 2.5
3 54 3.0
4 50 3.9
5 59 3.1
6 42 2.1
7 75 1.9
8 66 2.0
9 63 1.9
CAL: clinical attachment loss; PD: pocket depth.After removal of supragingival plaque, subgingival
plaque samples were taken separately from the mesio-
buccal and disto-buccal sites of pre-molars and first and
second molars using individual sterile Gracey curettes
and each sample placed in individual tubes containing
200 uL of RNAse-free TE buffer, immediately frozen and
stored at -80°C until processed.
Community DNA and RNA extraction
Cells were collected by centrifugation for 10 min at
maximum speed in a microcentrifuge. A total of 600 μL
of mirVana kit lysis/binding buffer and 300 μL of 0.1-
mm zirconia-silica beads (BioSpec Products, Bartlesville,
OK, USA) were added to the samples. The beads were
treated with DEPC overnight and autoclaved. Samples
were bead beaten for 1 min at maximum speed. DNA
and RNA were extracted simultaneously following the
protocol of mirVanaTM Isolation kit for RNA and To-
TALLY RNATM kit (Life Technologies) for DNA.
Eukaryotic DNA was removed using the MolYsis® kit
(Molzym GmbH & Co. KG, Bremen, Germany).
MICROBioEnrich (Life Technologies) was used to re-
move eukaryotic RNA and MICROBExpress (Life Tech-
nologies) to remove prokaryotic rRNA. All kits were
used following the manufacturers’ instructions.
DNA, RNA amplification, and Illumina sequencing
DNA amplification was performed using the Illustra
GenomiPhi V2 amplification kit (GE Healthcare Life Sci-
ences) according to the manufacturer’s instructions.
RNA amplification was performed on total bacterial
RNA using MessageAmpTM II-Bacteria RNA amplifica-
tion kit (Life Technologies) following the manufacturer’s
instructions. Sequencing was performed at the Forsyth
Institute. Illumina adapter-specific primers were used to
amplify and selectively enrich for the cDNA generated
from enriched mRNA. Quantified libraries were pooled
and sequenced using the MiSeq v2, 2×150 cycle cart-
ridge (Illumina). The Nextera XT kit was used tojects
Mean CAL (mm) Sites with PD ≥5 mm (%)
1.4 7%
1.8 15%
3.0 17%
3.3 41%
3.3 21%
2.5 3%
3.4 10%
2.2 7%
1.0 4%
Table 2 Clinical characteristics of progressing and stable sites
Subject Sitea Visit (months) PD (mm) CAL (mm) Progression (0/1)
1 361 0 3.0 2.0 1
361 2 5.0 4.0
1 353 0 2.5 1.5 0
353 2 3.0 2.0
2 473 0 3.0 2.0 1
473 2 5.0 4.0
2 241 0 3.0 1.0 0
241 2 3.0 2.0
3 273 0 4.0 4.0 1
273 2 8.5 8.0
3 441 0 4.0 3.0 0
441 2 3.0 2.0
4 143 0 6.0 5.0 1
143 2 8.0 7.0
4 453 0 4.5 3.5 0
453 2 5.0 4.0
5 151 0 3.0 3.0 1
151 2 5.0 5.5
5 373 0 3.0 3.0 0
373 2 3.0 3.0
6 143 0 2.0 2.0 1
143 4 4.0 4.0
6 151 0 1.5 2.5 0
151 2 1.0 2.0
7 253 0 2.5 2.5 1
253 4 5.0 5.0
7 141 0 2.0 3.0 0
141 2 3.0 3.5
8 253 0 3.5 3.5 1
253 2 5.5 5.5
9 353 0 2.0 1.0 0
353 2 2.5 1.5
aFirst two digits indicate tooth number according to the FDI World Dental Federation two-digit notation; third digit indicates site position: 1 - mesio-buccal,
3 - disto-buccal.
CAL: clinical attachment loss; PD: pocket depth.
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braries were pooled and sequenced using the 2×250
Miseq v2 cartridge.
Selection of genomes in databases
Genomes of archaea and bacteria as well as their associ-
ated information were downloaded from the HOMD
database server [26], the Pathosystems Resource Integra-
tion Center (PATRIC) ftp server [27,28], and the J. Craig
Venter Institute [29]. A total of 524 genomes from 312
species of bacteria and two genomes from one archaeaspecies were used in the analysis (Additional file 1: Table
S7). Viral genomes were downloaded from NCBI [30].
Short reads sequence alignment analysis
Low-quality sequences were removed from the query
files. Fast clipper and fastq quality filter from the Fastx-
toolkit [31] were used to remove short sequences with
quality score >20 in >80% of the sequence. Cleaned files
were then aligned against the bacterial/archaeal database
using bowtie2. We generated a .gff file to map hits to
different regions in the genomes of our database. Read
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multicov from bedtools [32].
Phylogenetic analysis of the metagenome and
metatranscriptome
Counts from the DNA and RNA libraries were used to
determine the phylogenetic composition of the respect-
ive libraries. We created a .gff file containing informa-
tion on whole genomes that was used to assign hits to
genomes. Abundance estimation at the species level was
performed applying the Genome Abundance Similarity
Correction (GASiC) proposed by Lindner and Renard to
estimate true genome abundances via read alignment by
considering reference genome similarities in a non-
negative LASSO approach [33]. Estimated counts were
normalized by frequency and log2 transformed before
final analysis. To identify significant differences between
communities under the different conditions studied we
performed linear discriminant analysis (LDA) effect size
(LEfSe) as proposed by Segata et al. [34], with default
settings.
Differential expression analysis
For assessing differential expression in genes within a
specific species we normalized the transcript counts by
the relative frequency of the species in the metagenome
database. In the case of Gene Ontology (GO) term ana-
lysis, we did not normalize by relative abundance since
we were treating the whole community as a single or-
ganism. To identify differentially expressed genes from
the RNA libraries, we applied non-parametric tests to
the normalized counts using NOISeqBIO function of the
R package NOISeq default conditions (k = 0.5, lc = 1,
replicates = ‘biological’ and rpkm normalization (rpkm op-
tion) using the threshold value for significance suggested by
the authors of q = 0.95, which for the function NOISeqBio
is equivalent to an FDR cutoff of 0.05 [35,36].
GO enrichment analysis
To evaluate functional activities differentially repre-
sented in health or disease, we mapped the differentially
expressed genes to known biological ontologies based
on the GO project [37]. GO terms to which the differ-
ent ORFs belong were obtained from the PATRIC
database [27]. GO terms not present in the PATRIC
database and whose annotation was obtained from the
HOMD database or from the J. Craig Venter Institute
were acquired using the program blast2GO under the
default settings [38].
Enrichment analysis on these sets was performed using
the R package GOseq, which accounts for biases due to
over-detection of long and highly expressed transcripts
[39]. Gene sets with ≤10 genes were excluded from ana-
lysis. We used the REVIGO web page [40] to summarizeand remove redundant GO terms from the results. Only
GO terms with FDR <0.05 were used. REVIGO plots
were obtained for biological processes categories.
Quantification of putative virulence factors
To identify putative virulence factors we used the Viru-
lence Factors of Pathogenic Bacteria Database (VFDB)
[41]. A similar approach, but with less stringent condi-
tions, has been used by other authors to identify putative
virulence factors in genomic islands [42]. The VFDB
contains 1,205 virulence factors and 5,955 virulence factor
related genes from 75 pathogenic bacterial genera [43]. We
performed a BLAST similarity search of encoded proteins
from the genomes in our database against the VFDB, with
an e-value cutoff of 10 to 25 and identity >99% to exclude
distant homologs.
Integration of metatranscriptomic results with clinical traits
To integrate omics results with clinical parameters we used
the R package mixOmics [44,45]. We calculated the sparse
partial least square (sPLS) correlations between the clinical
traits and species frequencies and profiles of gene expres-
sion in the progressing sites. Metatranscriptome hits were
normalized by frequencies obtained in the metagenome be-
fore mixOmix analysis. For gene expression profiles, low
count genes were filtered using the NOISeq function fil-
tered.data with filter 1 and a minimum count per million of
30 [36]. Correlation Circle plots were obtained on the sPLS
results to visualize associations between principal compo-
nents species and gene expression profiles. Relevance net-
works showing correlations between genes and clinical
traits were visualized in Cytoscape [46] with a threshold
correlation of 0.95.
Results
Phylogenetic differences between sites in metagenome
and metatranscriptome composition
The comparison of phylogenetic assignments of the
metagenome is presented in Figure 1. Two major obser-
vations can be derived from these results. First, changes
in the metagenome of non-progressing sites were minor,
only four species were significantly more abundant in
the community at the endpoint of our study (Figure 1A).
Second, differences in progressing sites were more sig-
nificant (Figure 1B) and in those Streptococcus spp. dom-
inated the community at baseline compared with the
progressing community. What was more striking was
the complete rearrangement at the metagenome level
between the baselines of sites that did not progress ver-
sus sites that did progress (Figure 1C). Additionally, we
compared the metagenome of baseline from progressing
sites and non-progressing sites with samples from
healthy sites of periodontally healthy individuals from a
previous study [1]. The metagenome composition of
Figure 1 (See legend on next page.)
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Figure 1 Statistical differences in metagenome composition. Metagenome hit counts were first normalized using GASIC. Normalized counts
were then analyzed using LEfSe with default parameters, to identify significant differences at species level between the microbial communities
compared. (A) Comparison baseline samples from active sites vs. progressing samples from active sites (that is, samples collect at the visit when
an increase in CAL ≥2 mm was detected). (B) Comparison baseline samples from stable sites vs. follow-up samples from stable sites (that is, collected 2
months after baseline). (C) Comparison baseline samples from active sites vs. baseline samples from stable sites.
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to healthy communities (Additional file 2: Figure S1).
Streptococcus spp. were more abundant in health than in
the non-progressing baseline, while known periodontal
pathogens such as T. denticola and T. forsythia were
more abundant in the baseline samples (Additional file
2: Figure S1A). However, Streptococcus spp. were more
abundant in the baseline from progressing sites than in
healthy samples (Additional file 2: Figure S1B).
We then looked at the fraction of the active community
under the conditions studied. To perform these analyses we
first normalized the metatranscriptome results by the rela-
tive abundance of the different species to obtain differences
in expression due to real changes in levels of gene expres-
sion and not to increases in numbers of certain members
of the community. Species frequencies were estimated
using GASIC [33]. Figure 2 shows the results of these ana-
lyses. As in the case of the metagenome, only a few species
were significantly more active in the non-progressing sites
at the end of the study (Figure 2A). When we compared
progressing sites to their baseline, and baselines from pro-
gressing and non-progressing sites, the differences were lar-
ger (Figure 2B and C). Streptococcus spp. dominated the
activity of the community at baseline of progressing sites
(Figure 2B). Moreover, a member of the red complex, P.
gingivalis, several members of the orange complex in-
cluding P. intermedia and E. nodatum, and the puta-
tive periodontopathogen Filifactor alocis were more
active at the baseline of active sites than the baseline of
non-progressing sites (Figure 2C).
As with the metagenome, we also compared the results
of activity at baseline and time of progression with the ac-
tivity of the community in healthy samples. When compar-
ing baseline of non-progressing sites to healthy sites, the
first obvious results was that a larger fraction of the com-
munity is more active in the baseline samples than in
health, even though they were clinically similar (Additional
file 2: Figure S2). The same could be said for the baseline
samples of sites that progressed; a large fraction of the com-
munity was significantly more active than the subgingival
communities in health (Additional file 2: Figure S3).
Community-wide changes in patterns of gene expression
in non-progressing and progressing sites during
periodontitis progression
We first characterized differences in gene expression be-
tween baseline and progression in sites that showeddisease activity during monitoring. We analyzed the glo-
bal behavior of the community by identifying enrich-
ment of GO terms. These results represent global
changes in the community and could be due to over-
expression of certain genes as well as increase in members
of the community whose contribution to the observed ac-
tivities is now higher due to their larger number. Potas-
sium and amino-acid transport, peptidoglycan catabolism,
isoprenoid biosynthesis, polysaccharide biosynthesis, and
protein kinase C-activating G-protein coupled receptor
signaling pathway were over-represented activities at
baseline when compared to the end point of progression
(Figure 3A). Over-represented activities at sampling time in
progressing sites are shown in Figure 3B. We observed an
over-representation of pathogenesis associated GO terms
as well as activities related to response to oxidative stress.
We normalized the hit counts against species fre-
quencies estimated using GASIC [33]. These normal-
ized counts represented actual over-expression at the
species level and not just increase in the total number
of individuals in the community. Interestingly, the list
of differentially expressed (DE) genes before and after
normalization was very similar (Additional file 2:
Figure S4). A total of 132,251 of the DE genes were
identical in both, normalized and no-normalized gene
sets; 412 DE genes were only identified exclusively in the
normalized list and only 6,126 in the no-normalized set of
DE genes. These results suggest that most of the differences
observed were due to changes in gene expression at the
species level rather than changes in the numbers of the
members of the community.
When we compared the expression profiles of baseline
and follow-up samples from non-progressing sites (that
is, sites that did not change based on CALs) we did not
identify any gene as differentially expressed, indicating that
clinically stable sites did not have significant changes in
gene expression during the period we studied those sites.
Changes in gene expression profiles in major periodontal
pathogens members of the red complex (P. gingivalis, T.
denticola, and T. forsythia) during periodontal disease
progression showed that upregulated genes belonged to
GO terms associated with transport (iron, cation, lactate,
citrate, sodium, and phosphate), proteolysis, protein kinase
C-activating G-protein coupled receptor signaling pathway
and response to antibiotic (Additional file 2: Figure S5A),
while downregulated genes belonged to GO terms associ-
ated with cobalamin (vitamin B12) biosynthesis (Additional
Figure 2 (See legend on next page.)
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Figure 2 Statistical differences in metatranscriptome normalized composition. Metatranscriptome hits were first normalized by the relative
frequency of species obtained in the metagenomic analysis using GASIC. Normalized counts were then analyzed using LEfSe with default
parameters to identify significant differences in activity at the species level. (A) Comparison baseline samples from active sites vs. progressing
samples from active sites (that is, samples collect at the visit when an increase in CAL ≥2 mm was detected). (B) Comparison baseline samples
from stable sites vs. follow-up samples from stable sites (that is, collected 2 months after baseline). (C) Comparison baseline samples from active
sites vs. baseline samples from stable sites.
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nema denticola upregulated genes related to flagella bio-
synthesis (flaA, flaG, fliQ, and fliW), oligopeptide ABC
transporters, and a large number of hypothetical proteins
(Additional file 3: Table S1). Tannerella forsythia and Por-
phyromonas gingivalis both upregulated different TonB-
dependent receptors, genes involved in iron transport
(ferric uptake siderophores and ferrous iron transport pro-
tein B), a large number of peptidases and proteases includ-
ing ClpB, genes associated with aerotolerance (Bacteroides
aerotolerance operon batA-E and moxR-like ATPase of
the aerotolerance operon), and CRISPR- associated genes
(csp, csm, and cas genes) (Additional file 3: Table S1).
Finally, P. gingivalis specifically upregulated genes
related to biotin synthesis (biotin synthase, bioC, andA
Figure 3 GO enrichment analysis comparing baseline in active sites t
using GOseq were summarized and visualized as a scatter plot using REVIG
baseline. (B) Summarized GO terms related to biological processes in prog
while color indicates the log10 P value (red higher, blue lower).bioG), capsular polysaccharide biosynthesis proteins and
a large number of proteins of conjugative transposons
(traA, traB, traE, traF, traG, traI, traJ, traK, traL, traM,
traN, traO, trap, and traQ) and transposases (ISPg2,
ISPg3, ISPg4, ISPg5, and ISPg6). T. forsythia specifically
upregulated transposases (IS116, IS110, IS902, and IS4
families) and large numbers of different homologs of
SusC and SusD family proteins, involved in polysacchar-
ide binding. Regarding downregulated proteins of the
red complex most of them were hypothetical in all three
of its members (Additional file 4: Table S2).
Profiles of expression of the members of the orange
complex were very similar to the ones from the red
complex. They upregulated different TonB-dependent
receptors, a large number of peptidases and proteasesB
o progression profiles in the same sites. Enriched terms obtained
O. (A) Summarized GO terms related to biological processes at
ression. Circle size is proportional to the frequency of the GO term,
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(Bacteroides aerotolerance operon batA-E i and moxR-
like ATPase of the aerotolerance operon in P. intermedia
and P. nigrescens), genes involved in iron transport
(ferric uptake siderophores and ferrous iron transport
protein B), hemolysins, CRISPR- associated genes (in C.
gracilis, C. rectus, C. showae, P. nigrescens, and S. con-
stellatus) and chaperones GroEL, GroES, and GrpE
(Additional file 5: Table S3). As in the case of P. gingiva-
lis, both P. intermedia and P. nigrescens upregulated a
large number of mobilization genes from conjugative
transposons (traA, traB, traD, traE, traF, traG, traI, traJ,
traK, traL traM, traN, traO, and traQ) (Additional file
5: Table S3).
Comparison of metatranscriptomic profiles from
progressing vs. non-progressing sites at baseline
In order to identify activities that could be related to
the initial steps of disease progression we compared
community-wide expression profiles of samples at
baseline from sites that did not progress vs. sites that
did. The analysis of GO enrichment terms showed anA
Figure 4 GO enrichment analysis comparison of baselines from progr
goseq were summarized and visualized as a scatter plot using REVIGO. (A)
progressing sites. (B) Summarized GO terms related to biological processes
frequency of the GO term, while color indicates the log10 P value (red highover-representation in the baseline of progressing sites
of terms related to cell motility, transport (iron, potas-
sium, chloride, citrate, and amino acids transport),
lipid A and peptidoglycan biosynthesis, protein kinase
C-activating G-protein coupled receptor signaling
pathway, as well as synthesis of aromatic compounds
(Figure 4A). On the other hand, in the baseline sam-
ples from non-progressing sites there was an over-
representation of GO terms related to tricarboxylic
acid cycle, metal ion transport, phosphoenolpyruvate-
dependent sugar phosphotransferase system and pro-
tein secretion (Figure 4B).
When compared baselines with healthy sites we
found that the clinically healthy sites at baseline from
diseased individuals were already impacted by disease.
Both baselines from progressing and non-progressing
sites had an over-representation of GO terms associ-
ated with citrate, organic ion, and lactate transport, as
well as sulfur compound metabolic processes and pep-
tidoglycan catabolism (Additional file 2: Figure S6).
Differences in gene expression of the red complex
between baseline samples from progressing vs. non-B
essing and non-progressing sites. Enriched terms obtained using
Summarized GO terms related to biological processes in baselines of
in baselines of non-progressing sites. Circle size is proportional to the
er, blue lower).
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when studying progressing sites. GO assignment of the dif-
ferentially expressed genes showed association with prote-
olysis, sulfur compound metabolism and response to
antibiotic in upregulated genes and translation in
downregulated genes (Additional file 2: Figure S7). P.
gingivalis actively upregulated putative virulence fac-
tors (34 in total) while T. denticola, with three upregu-
lated putative virulence factors, and T. forsythia, with
one, seem not especially active at this stage (Additional
file 6: Table S4).
A more complex picture emerged when we analyzed
the behavior of the orange complex. As a whole the
members of the orange complex (P. intermedia, P.
nigrescens, P. micra, F. nucleatum, F. periodonticum, C.
gracilis, C. rectus, S. constellatus, E. nodatum, and C.
showae) showed upregulation of genes associated with
proteolysis, sodium ion transport, cellular response to
phosphate starvation, and regulation of pH (Additional
file 2: Figure S8A).A
Figure 5 Ranked species by the number of upregulated putative v
factors were identified by alignment of the protein sequences from the
as described in the Methods section. Numbers in the graph refer to the
virulence factors identified. The numbers correspond to the total hits to
and they could be redundant. In red are members of the red complex.
baseline to progressing. (B) Comparison of baseline non-progressing toExpression of putative virulence factors in the oral
community during periodontitis progression and at baseline
of progressing vs. baseline of non-progressing sites
In the case of progressing sites, when comparing base-
line vs. break down visit, a total of 9,147 hits of putative
virulence factors from 207 species were identified in the
genes over-represented in progressing samples. None-
theless, not all of them expressed a large number of
them, only 47 showed upregulation of 50 or more puta-
tive virulence factors under these conditions. Two mem-
bers of the red complex, P. gingivalis and T. forsythia,
expressed a large number of the putative virulence fac-
tors in the progressing samples (Figure 5A). More active
in these samples were members of the orange complex:
C. gracilis, F. nucleatum, P. intermedia, S. constellatus,
P. nigrescens, and P. micra (Figure 5A). Three members
of this complex were especially active in the upregula-
tion of putative virulence factors: C. gracilis, F. nuclea-
tum, and P. intermedia upregulated 114, 90, and 82
genes, respectively, that have homology with virulenceB
irulence factors in the metatranscriptome. Putative virulence
different genomes against the Virulence Factors Database (VFDB)
absolute number of hits for the different species for the putative
different strains corresponding to the species in our database
In orange are members of the orange complex. (A) Comparison of
baseline progressing.
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micra upregulated 69 putative virulence factors, P.
nigrescens 73, S. constellatus 79, C. rectus 13, and C. sho-
wae 11. We did not identify any putative virulence factor
upregulated from E. nodatum or from F. periodonticum.
When we looked at the global activities associated with
the expression of these virulence factors we obviously
observed an over-representation of GO terms related to
pathogenesis as well as iron transport and lipid A bio-
synthesis (Additional file 2: Figure S9A). Focusing on the
members of the red complex we could also see as com-
mon themes an up-regulation of genes associated with
iron transport and lipid A biosynthesis (Additional file 2:
Figure S9B). More interestingly were the results associ-
ated with the orange complex. In addition to the same
activities mentioned for the red complex, members of
the orange complex upregulated genes involved in cell
adhesion, proteolysis, and pilus assembly during progres-
sion (Additional file 2: Figure S9C).
We then looked at the global activities associated with
the expression of virulence factors comparing baselines
of non-progressing vs. progressing sites and found that
in the baseline of progressing sites the major activities
corresponded to pathogenesis and ferrous ion transport
while in non-progressing baselines there was an over-
representation of GO terms related to cobalamin biosyn-
thesis and sodium ion transport (Additional file 2: Figure
S10). Comparing the expression of virulence factors at
baseline gave a better understanding of the role of two
complexes (red and orange) in the first stages of disease.
We did not observe a significant over-representation of
any GO terms in any of the members of the red com-
plex. Nonetheless, members of the orange complex were
indeed upregulating genes involved in proteolysis and
iron homeostasis (Additional file 2: Figure S11). Surpris-
ingly enough, we identified a set of organisms that were
highly active, transcribing genes of putative virulence
factors that have not been usually associated with peri-
odontal disease. S. oralis, S. mutans, S. intermedius, S.
mitis, V. parvula, and P. fluorenscens were upregulating
a large number of putative virulence factors in both analysis
(baseline vs. progression, comparing baseline in progression
with baseline in non-progressing sites) (Figure 5).
All of the above cited organisms upregulated different
oligopeptide transport systems (oppA, oppD, oppF, and
oppB). S. oralis, S. mutans, S. intermedius, S. mitis, P. fluor-
enscens, and V. parvula upregulated several hemolysins,
manganese ABC transporters, manganese superoxide dis-
mutase, and a protein serine threonine phosphatase (PrpC)
involved in regulation of stationary phase (Additional file 8:
Table S6). S. oralis, S. mitis, and V. parvula upregulated
vitamin B12 ABC transporters (Additional file 8: Table S6).
S. oralis, S. mutans, S. intermedius, and S. mitis all upregu-
lated Clp protease and LytR trancriptional attenuator. P.fluorescence upregulated all genes associated with flagellar
synthesis (flaA, flaG, fleN, flgA, flgC, flgF, flgI, flgJ, flgK, flgN,
flhA, flhB, flhF, fliD, fliF, fliG, fliI, fliK, fliN, fliP, fliQ, fliR,
fliS, and motB) and genes related to chemotaxis (Additional
file 8: Table S6).
In spite of the commonalities in upregulated genes
when comparing baselines of progressing to non-
progressing sites and progression, there were also spe-
cific signatures of the two comparisons. For instance, S.
oralis and S. mitis upregulated collagen adhesion pro-
teins and V. parvula TonB-dependent receptors when
comparing baselines but not during progression.
Integrating expression profiles and clinical traits during
periodontitis progression
Integrating microbiological functions with clinical parame-
ters is still one of the challenges in omics analysis. We used
multivariate statistical analysis and visualization tools im-
plemented in the R package mixOmics [44] to identify rele-
vant associations between gene expression and certain
clinical traits: bleeding on probing (BOP), increase in
pocket depth (ΔPD) and increase in clinical attachment
level (ΔCAL). We calculated the sparse partial least square
(sPLS) correlations between the evolution of clinical traits
and profiles of gene expression in the progressing sites.
Additional file 2: Figure S12 visualizes of the relationships
using correlation circle plots. Not surprisingly, ΔPD and
ΔCAL were highly correlated between them (Additional file
2: Figure S12A). There was a set of genes whose
expression profiles were highly correlated with ΔPD
and ΔCAL evolution (Additional file 2: Figure S12A).
There were no genes whose profiles correlated with
BOP (Additional file 2: Figure S12). Interestingly, two
large set of genes correlated with other components
(Additional file 2: Figure S12B), but which possibly
corresponded to another clinical trait not analyzed in
our study.
We also analyzed correlation structures between clin-
ical traits and gene expression using relevance networks
[44]. This method generates a graph where nodes repre-
sent variables and the edges represent the correlations.
The correlation of gene expression profiles gave a large
number of genes that correlated with the clinical param-
eter profiles. Not surprisingly, BOP, which is a dichot-
omous variable with only two states (yes or no), did not
correlate with any gene profiles. ΔPD and ΔCAL corre-
lated with a large number of gene profiles, even with an
r = 0.95. We then assigned GO terms to the correlated
genes and summarized these results using REVIGO. We
detected specific patterns of activities associated with in-
creases in PD and CAL (Figure 6A and B). Among those
patterns we found that the profiles of expression of
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Figure 6 GO assignment terms for genes with relevance networks associations with clinical parameters. Relevance networks were
obtained using the first three sPLS dimensions. We used a threshold of r = 0.95 to select for association between progression of clinical
parameters (ΔPD increase in pocket depth, ΔCAL increase in clinical attachment level) and gene expression profiles. GO terms were assigned to
genes whose pattern of expression was significantly associated with the clinical parameters measured. GO terms were summarized using REVIGO.
(A) GO terms associated with ΔPD. (B) GO terms associated with ΔCAL.
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parameters.Viral activity in the oral cavity during progression
We also looked at the presence of eukaryotic viruses and
bacteriophages, which have been previously associated
with disease [47] and may play a role in shaping the bac-
terial community [48]. We identified viral activities in all
samples although the number of transcripts represented
a small fraction of all hits identified, between 0.04% and
0.7% of all hits were of viral origin (Additional file 2:
Figure S13). To confirm that those hits really belong to
viral sequences we obtained consensus sequences from
the .bam files of our alignments and BLASTed them
against the nr database at NCBI. Consensus sequence
from 14 out of the 16 samples analyzed had sequences
with significant matches to viral sequences. When we
compared the relative activities of viruses at baseline and
progression, we observed high activity of phages andherpesvirus in the progressing sites in relation with the
baseline samples (Additional file 2: Figure S14).Discussion
In a recent report we used a combined metagenomic/
metatranscriptomic approach to characterize the func-
tional dysbiotic phenotype of the oral microbiome dur-
ing severe chronic periodontitis. We took advantage of
next generation sequencing (NGS) techniques and the
fact that a large number of genomes from oral isolates
have been sequenced [49] to infer functional differences
between the subgingival microbiota of periodontal health
and chronic severe periodontitis [1]. To date, only a few
studies have been used to study the transcriptome of the
community-wide oral microbiome, either to characterize
microbial expression in caries [50,51] or periodontitis
[52] but none of them addressed the question of why
some dental site suffer peridontitis progression while
other remain stable.
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NGS analysis compared samples from periodontally healthy
subjects with chronic periodontitis samples reached similar
conclusions and suggested that members of the genera Pre-
votella, Fusobacterium, Treponema, Sinergistetes, Filifactor,
and Porphyromonas and candidate division TM7 were
more abundant in periodontitis whereas Actinomyces and
Streptococcus were less frequent in samples from periodon-
titis compared to periodontally healthy subjects [10,11].
These results agreed with the associations of red and or-
ange complexes with periodontal disease previously postu-
lated using other detection methods [9,53]. We observed
similar results in our previous study when comparing
health and severe chronic periodontitis [1]. Although most
analyses were performed using 16S rDNA sequencing and
our current study used metagenomic analysis (shot gun se-
quencing using NGS), we also found that in the progressing
sites Prevotella and Sinergistetes were more abundant when
the teeth broke down than at baseline while the opposite
was true for the genus Streptococcus. Non-progressing sites
had almost the same metagenomic composition at baseline
and at the 2-month visit, when another sample was taken.
Examining baseline samples might give us insights into
the changes in microbial composition and activities that
define the initial stages of progression. Large differences
were observed when comparing baseline samples of
progressing with non-progressing sites. Members of
the genera Porphyromonas, Treponema, Tannerella, and
Prevotella, among others, were more abundant at base-
line on sites that progressed. Members of the genus
Streptococcus were more abundant at baseline in non-
progressing sites.
We also looked at differences in the phylogenetic as-
signment of active members of the microbial commu-
nity. We found that, as in the metagenome, no major
differences were observed in stable sites when compar-
ing baseline and 2-month visit samples. However, the
differences where profound when we compared progres-
sing sites at baseline with the breakdown time point and
even more profound when we compared the two base-
line samples from progressing and non-progressing sites.
During progression Streptococcus spp. and Actinomyces
spp. were highly active at baseline. In contrast Myco-
plasma spp. were more active in progression. Although
little attention has been paid to Mycoplasma spp. as po-
tentially important in oral diseases in most studies, it
has been significantly associated with periodontitis
[10,11,54,55]. Interestingly, Synergistites sp. and the ar-
chaea Methanobrevibacter sp. were more active during
progression. These microorganisms have been previously
associated with periodontal disease [10,11,56].
When we looked at differences at baseline between ac-
tive and non-progressing sites we found that the known
periodontal pathogens T. denticola and T. forsythia werenot significantly more active while P. gingivalis was. P.
gingivalis has been proposed as a keystone-pathogen
in periodontitis. The keystone-pathogen hypothesis states
that specific low-abundance microbes can lead the process
of periodontal inflammation and tissue destruction by
transforming a normally healthy microbiome into a dysbio-
tic state [57,58]. The high activity of P. gingivalis at baseline
of active sites will agree with this hypothesis and it
would indicate that even at early stages P. gingivalis is
starting to be involved in the dysbiotic process that
leads to progression.
Additionally, F. alocis, E. nodatum, and several Prevotella
spp. were more active in the sites that would progress than
in the site that would remain non-progressing. Both F.
alocis and E. nodatum, a member of the orange complex,
have been previously associated with periodontal disease
[55,59-61].
Testing for differential representation of GO terms
gives an overall view of the metabolic activities of the
whole community under different environmental condi-
tions. Interestingly, when we compared the expression
profiles of longitudinal samples from stable sites, we did
not identify any gene as differentially expressed. This in-
dicates that the community as a whole did not change
its expression patterns in the two months between the
first visit and the time when subsequent samples were
taken.
When we looked at progression, the results pointed to
several functional signatures characteristic of the active
sites. At the breakdown point active sites were actively
expressing genes associated with pathogenesis, response
to oxidative stress and ferrous iron transport. Oxidative
stress is one of the consequences of the host inflamma-
tory response to the microbial challenge [62] and bac-
teria must act to defense themselves against this host
defense mechanism, which is probably accentuated with
the progression of disease. Iron is an essential enzymatic
cofactor and we have already shown the in situ over-
expression of genes related to its transport in the micro-
bial community during severe chronic periodontitis [1].
At baseline, GO terms associated with isoprenoid and
polysaccharide biosynthesis, sulfur compound metabolic
processes, potassium ion transport and protein kinase
C-activating G-protein coupled receptor signaling path-
way were highly enriched. Lipopolysaccharide (LPS) is a
key factor in the development of periodontitis [63,64]
and high levels of lipopolysaccharide (LPS) from P. gin-
givalis have been reported to delay neutrophil apoptosis
and provide a mechanism to modulate the restoration
and maintenance of inflammation in periodontal tissues
[65-67]. Hydrogen sulfide production from aminoacids
and peptides has been reported in periodontal bacteria
and the different efficiency of use of these compounds
could be important determinants of the periodontal
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representation of GO terms related to potassium trans-
port. Potassium transport systems have been associated
with pathogenesis in other organisms such as Staphylo-
coccus aureus [70] and Salmonella [71], but not in oral
bacteria. Interestingly, significant higher levels of potas-
sium have been reported in periodontitis in both gingival
crevicular fluid (GCF) and saliva [72,73].
Comparing baseline metabolic activities of non-
progressing vs. progressing sites might give us a better
understanding of the initial stages of disease and the
role that the microbial community plays at this early
stage of pathogenesis. Among those functional signa-
tures we found: citrate transport, iron transport,
potassium transport, amino-acid transport, isoprenoid
biosynthesis, and ciliary and flagellar motility. Citrate
transport has been linked to iron transport and
virulence in other organisms, such as Shigella and
Pseudomonas [74,75]. This is in accordance with our
previous observations in severe chronic periodontitis
sites [1]. As mentioned above, the efficiency in utiliz-
ing various amino acids and peptides is among the key
determinants of the periodontal microbial ecology [68]
and its uptake may give additional advantages to cer-
tain members of the microbial community. In the ac-
tive sites, there seems to be a shift from amino-acid
uptake to oligopeptide uptake throughout the break-
down process. Isoprenoid biosynthesis, probably in-
volved in the synthesis of peptidoglycan, was also
over-represented in active sites. Isoprenoids are a
large, diverse class of naturally occurring organic che-
micals which are essential for cell survival. The 2C-
methyl-D-erythritol 4-phosphate (MEP) pathway has
been implicated in the virulence of Listeria monocyto-
genes, Mycobacterium tuberculosis, and Brucella abor-
tus [76], and evidence suggests that the MEP pathway
may be involved in intracellular survival by combating
oxidative stress [77]. Moreover, a metagenomic ana-
lysis of the human distal gut microbiome revealed that
MEP pathway genes are highly abundant in that com-
munity; perhaps reflecting the abundance of the MEP
pathway in bacteria in general [78]. Finally, ciliary and
flagellar motility as well as chemotaxis genes that
could direct bacterial movement were all part of the
signature activities at the initial stages of progression.
Motile pathogenic members of the oral community,
such as Treponema spp., possess the capacity for tissue
invasion thanks to the synthesis of flagella [79,80]; our
results suggest that this fraction of the community is
already active at the initial stages of progression.
Historically, members of the red and orange com-
plexes have been associated with chronic periodontitis
[7,9]. Consistent with their postulated role in progres-
sing sites, we observed a high level of expression ofputative virulence factors by members of both complexes
when breakdown was clinically detected. However, at the
baseline of our studies it seems that the relative importance
of these complexes in the active sites is reduced. Only P.
gingivalis, S. constellatus, and P. intermedia were actively
expressing putative virulence factors.
Interestingly, members of the red complex showed
enrichment in response to antibiotics (beta-lactamase
activity) during progression and even at baseline of pro-
gressing sites. We observed the same phenomenon at
whole community-level in our previous study comparing
healthy sites vs. chronic severe periodontitis [1]. Beta-
lactamase activity has been observed in adult periodontitis
at low-level enzymatic activity but with high prevalence
[81] and seems to be a frequent phenomenon in samples
from polymicrobial diseases [82]. We still do not know
what role this enzymatic activity plays on the progression
of the disease given that the patients of this study were not
treated with antibiotics at the time of sampling.
CRISPR- associated genes in P. gingivalis, T. forsythia,
C. gracilis, C. rectus, C. showae, P. nigrescens, and S. con-
stellatus were highly upregulated during progression.
We observed phage activity in all samples analyzed,
which could explain the high level of production of
CRISPR-associated proteins as a mechanism of defense
against viral activity [83]. However, we cannot discard
the possibility that CRISPR-associated proteins are play-
ing a broader role in the virulence mechanisms of peri-
odontitis. Thus, recently CRISPR-Cas systems have been
linked to stress responses and virulence in bacteria [84]
and to competitive interactions between members of the
red complex [85].
P. gingivalis, P. nigrescens, and P. intermedia upregu-
lated all the traA-Q and mob genes in their chromo-
somal conjugative transposons. These genes are required
for formation of a conjugal pore and DNA mobilization
[86,87]. The upregulation of these genes could indicate
conjugative transposons mobilization in Porphyromonas
and Prevotella which would agree with evidence of nat-
ural horizontal transfer of antibiotic resistance through
conjugative transposon mobilization in those organisms
[87-89]. However, the mobilization of those conjugative
transposons was most likely driven by the presence of
antibiotics. In the current study, subjects did not use
systemic antibiotics during the monitoring period when
samples were collected. Therefore, it is not clear what
signal(s) triggered this mobilization of conjugative trans-
posons. It is noteworthy that we did not observe this
phenomenon in severe chronic periodontitis samples [1].
The idea that the whole community acts as a pathogen
rather than only specific organisms has been gaining
traction in recent years [1,90,91]. In agreement with this
hypothesis we found that a group of organism not
usually considered pathogens were upregulating a large
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Among these groups, we observed that some strepto-
cocci, including S. mitis and S. intermedius, were espe-
cially active. Although S. mitis and S. intermedius are
usually associated with periodontal health, they have also
been found to form part of the community in periodon-
titis [10,11]. We found V. parvula highly active in both
progressing and baseline sites, which was surprising
since V. parvula is almost always associated with a healthy
community [10,23]. However, streptococci and V. parvula
have been identified as part of a cluster associated with
periodontitis in adolescents [92]. Another surprising finding
was the identification of P. fluorescens as one of the top
producers of virulence factors. This is not an organism usu-
ally associated with periodontitis, although another mem-
ber of its genus, P. aeruginosa, has indeed been associated
with other important pathologies such as cystic fibrosis
[93,94]. In our previous study on chronic severe periodon-
titis, we also observed a similar behavior where the whole
community, and not only known periodontal pathogens,
expressed more putative virulence factors in diseased sites.
Among the most active producers of putative virulence fac-
tors was Corynebacterium matruchotii [1], which has also
been associated with periodontitis in microbiome studies.
Interestingly, we also found this organism as highly active
in progressing sites but not at the baseline, indicating a shift
into a pathogenic microbial community.
We then established association between profiles of
clinical parameters such as BOP, ΔPD, and ΔCAL with
profiles gene expression. BOP showed no association
with changes in gene expression profiles. This is not sur-
prising since BOP is a discrete variable. Nonetheless,
ΔPD and ΔCAL were highly associated with proteolytic
activity and potassium ion transport. Additionally, ΔPD
was associated with cobalamin biosynthesis and ferrous
and oligopeptide transport. Proteolysis has been recog-
nized as an important virulence determinant in peri-
odontitis progression [95,96]. In the case of vitamin B12
(cobalamin) synthesis, we observed an upregulation of
the vitamin B12 ABC transporter btuFCD system in P.
gingivalis and T. forsythia and some members of the or-
ange complex. P. gingivalis harbors all the genes necessary
to convert precorrin-2 into cobalamin, but it lacks the
genes for the synthesis of precorrin-2 [97]. In our previous
study on chronic severe periodontitis we also observed an
up-regulation of btuFCD system in P. gingivalis and T. for-
sythia [1]. An increase in synthesis and release to the exter-
nal medium by other organisms of cobalamin might give
members of the red and orange complex an ecological ad-
vantage if they start scavenging it.
Conclusions
The initial causes for transition from a healthy microbial
community to a dysbiotic one are still not well understoodin great part due to the complexity of the oral community.
Using a metagenomic/metatranscriptomic approach, and
comparing baseline samples from the same individuals, we
have begun the study of the physiological changes in the
microbial community that are associated with the initial
stages of dysbiosis. Here, we show that in periodontitis pro-
gression there are certain characteristic activities that are
associated with the onset of breakdown in specific teeth.
Among those we found that citrate transport, iron trans-
port, potassium transport, amino-acid transport, isoprenoid
biosynthesis, and ciliary and flagellar motility are signatures
of the initiation of periodontitis progression.
The data presented here illustrate that regardless of
the overall composition of the community, certain meta-
bolic signatures are consistent with disease and progres-
sion. For instance, the community composition in the
progressing active sites was relatively different from the
Massachusetts in chronic severe periodontitis sites previ-
ously described [1]. Nonetheless, in both cases we observed
that iron transport and protein secretion activities are
highly associated with advance stages of disease. Moreover,
as we have shown in our previous study on chronic severe
periodontitis [1], our results show that the whole commu-
nity, and not just a handful of oral pathogens, is responsible
for an increase in virulence that could lead to progression.
Finally, we found that certain ecological changes could ex-
plain the evolution of certain clinical parameters. As we dis-
cuss above, an increase in production of cobalamin could
exacerbate the growth of periodontal pathogens that lack
the capabilities to synthesis this compound and explain, at
least in part, the association of these organisms with in-
crease in disease severity.
Availability of supporting data
The datasets used in these analyses were deposited at the
Human Oral Microbiome Database (HOMD) under the
submission numbers 20130522 [98] and 20141024 [99].
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Additional file 1: Table S7. List of genomes used in the study. We
generated a database of genomes that contains 524 genomes from 312
species of Bacteria and one species of Archaea and was used for
alignment of the sequences in our results.
Additional file 2: Figure S1. Statistical differences in metagenome
composition. Figure S2. Statistical differences in normalized
metatranscriptome composition comparing non-progressing sites
baselines to healthy sites of healthy patients. Figure S3. Statistical
differences in normalized metatranscriptome composition comparing
progressing sites baselines to healthy sites of healthy patients. Figure S4. Venn
diagram showing overlapping differentially expressed genes with and
without normalization. Figure S5. GO terms associated with changes in
gene expression profiles in major periodontal pathogens members of
the red complex during periodontal disease progression. Figure S6. GO
enrichment analysis comparing healthy sites from healthy individuals and
baselines in progressing sites and non-progressing sites. Figure S7. GO
terms associated with changes in gene expression profiles in major
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baselines of progressing and non-progressing sites. Figure S8. GO terms
associated with changes in gene expression profiles in members of the
orange complex when comparing baselines of progressing and
non-progressing sites. Figure S9. GO terms associated with changes
in gene expression of putative virulence factors in the oral community
during periodontitis progression. Figure S10. GO terms enrichment analysis
of virulence factors comparing baselines. Figure S11. GO terms enrichment
analysis of virulence factors in the orange complex comparing baselines.
Figure S12. Correlation circle plots of sPLS analysis. Figure S13. Percentage
of hits corresponding to viral sequences. Figure S14. Statistical differences in
viral composition of transcript libraries.
Additional file 3: Table S1. Upregulated genes in members of the
red complex during periodontal disease progression. After identifying
upregulated genes of the whole community we selected those
upregulated genes corresponding to the red complex (Porphyromonas
gingivalis, Treponema denticola, and Tannerella forsythia), which are
consider major periodontal pathogens.
Additional file 4: Table S2. Downregulated genes in members of the
red complex during periodontal disease progression. After identifying
downregulated genes of the whole community we selected those
downregulated genes corresponding to the red complex (Porphyromonas
gingivalis, Treponema denticola, and Tannerella forsythia), which are
consider major periodontal pathogens.
Additional file 5: Table S3. Differentially expressed genes in members
of the orange complex. Members of the orange complex (P. intermedia,
P. nigrescens, P. micra, F. nucleatum, F. periodonticum, C. gracilis, C. rectus,
S. constellatus, E. nodatum, and C. showae) have been also associated
with chronic periodontitis. Here were showed DE genes of the members
of this complex during periodontal disease progression.
Additional file 6: Table S4. Differentially expressed (DE) putative
virulence factors of the red complex when comparing the baseline
expression profiles of active and inactive sites. Based on the VFDB
(see Methods) we compared expression of DE putative virulence factors
at baseline and selected those corresponding to the red complex.
Additional file 7: Table S5. Differentially expressed (DE) putative
virulence factors of the orange complex when comparing the baseline
expression profiles of active and inactive sites. Based on the VFDB (see
Methods) we compared expression of DE putative virulence factors at
baseline and selected those corresponding to the orange complex.
Additional file 8: Table S6. Upregulated virulence factors in highly
active members of the community in progressing sites. Other members
of the community, usually not considered pathogens, showed a large
number of putative virulence factors being upregulated during periodontitis
progression and at baseline of progressing sites. Here we summarized the
results showing the species whose upregulation of putative virulence factors
was high, along with locus ID and annotation of the genes according to
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